American Shared Hospital Services Announces Second Quarter Financial Results Conference Call
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has scheduled its Q2 2025 earnings conference call for August 13, 2025, at 1:00 PM ET. The company will release its financial results before market opens on the same day.
Investors can join the call by dialing 1-844-413-3972 (domestic) or 1-412-317-5776 (international). A webcast will be available through the company's website. A replay will be accessible until August 20, 2025, using access code 3350902.
American Shared Hospital Services (NYSE American: AMS), fornitore di apparecchiature per la radiochirurgia stereotassica e servizi avanzati di radioterapia per il trattamento del cancro, ha programmato la sua conference call sui risultati del secondo trimestre 2025 per il 13 agosto 2025 alle 13:00 ET. La società pubblicherà i risultati finanziari prima dell'apertura dei mercati lo stesso giorno.
Gli investitori possono partecipare alla chiamata componendo il numero 1-844-413-3972 (nazionale) o 1-412-317-5776 (internazionale). Sarà disponibile una trasmissione web tramite il sito web dell'azienda. Una registrazione sarà accessibile fino al 20 agosto 2025 utilizzando il codice di accesso 3350902.
American Shared Hospital Services (NYSE American: AMS), proveedor de equipos de radiocirugía estereotáctica y servicios avanzados de radioterapia para el tratamiento del cáncer, ha programado su llamada de conferencia de resultados del segundo trimestre de 2025 para el 13 de agosto de 2025 a la 1:00 PM ET. La compañía publicará sus resultados financieros antes de la apertura del mercado ese mismo día.
Los inversores pueden unirse a la llamada marcando el 1-844-413-3972 (nacional) o 1-412-317-5776 (internacional). Habrá una transmisión web disponible a través del sitio web de la empresa. Una repetición estará accesible hasta el 20 de agosto de 2025 utilizando el código de acceso 3350902.
American Shared Hospital Services (NYSE American: AMS)는 정위 방사선 수술 장비 및 첨단 방사선 암 치료 서비스를 제공하는 회사로, 2025년 8월 13일 오후 1시(동부시간)에 2025년 2분기 실적 컨퍼런스 콜을 예정하고 있습니다. 회사는 같은 날 시장 개장 전에 재무 결과를 발표할 예정입니다.
투자자들은 국내 전화번호 1-844-413-3972 또는 국제 전화번호 1-412-317-5776로 전화를 걸어 참여할 수 있습니다. 회사 웹사이트를 통해 웹캐스트도 제공됩니다. 재청취는 2025년 8월 20일까지 접속 코드 3350902를 사용해 이용할 수 있습니다.
American Shared Hospital Services (NYSE American : AMS), fournisseur d’équipements de radiochirurgie stéréotaxique et de services avancés de radiothérapie pour le traitement du cancer, a programmé sa conférence téléphonique sur les résultats du deuxième trimestre 2025 le 13 août 2025 à 13h00 ET. La société publiera ses résultats financiers avant l’ouverture des marchés ce même jour.
Les investisseurs peuvent rejoindre l’appel en composant le 1-844-413-3972 (domestique) ou le 1-412-317-5776 (international). Un webcast sera disponible via le site internet de la société. Un replay sera accessible jusqu’au 20 août 2025 en utilisant le code d’accès 3350902.
American Shared Hospital Services (NYSE American: AMS), Anbieter von stereotaktischer Radiochirurgie-Ausrüstung und fortschrittlichen Strahlentherapie-Diensten zur Krebsbehandlung, hat seine Telefonkonferenz für die Quartalsergebnisse Q2 2025 für den 13. August 2025 um 13:00 Uhr ET geplant. Das Unternehmen wird seine Finanzergebnisse am selben Tag vor Markteröffnung veröffentlichen.
Investoren können der Telefonkonferenz unter der Nummer 1-844-413-3972 (national) oder 1-412-317-5776 (international) beitreten. Ein Webcast ist über die Unternehmenswebsite verfügbar. Eine Aufzeichnung wird bis zum 20. August 2025 mit dem Zugangscode 3350902 abrufbar sein.
- None.
- None.
Call Scheduled for August 13th at 1:00 PM ET
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing and direct patient care services segments, today announced that the Company will hold a conference call to discuss its second quarter 2025 financial results on August 13th at 1:00 pm ET.
The second quarter 2025 financial results press release will be issued before the market opens on August 13th.
Teleconference and Webcast Information
To participate, domestic callers may dial 1-844-413-3972 and international callers may dial 1-412-317-5776 at least 10 minutes prior to the start of the call and ask to join the American Shared Hospital Services call.
A simultaneous webcast of the call may be accessed through the Company's website, www.ashs.com or directly:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=uJ5x0Ugn
A replay of the call will be available at 1-877-344-7529 or 1-412-317-0088, access code 3350902, through August 20, 2025. The call will also be available for replay on the Company’s website at www.ashs.com.
About American Shared Hospital Services (NYSE American: AMS)
American Shared Hospital Services (AMS) is a leading provider of turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America. The company works closely with its partners to develop and grow their cancer service lines and provide integrated cancer care to patients in a convenient local setting close to home. For centers under health system partnerships, the Company and its health system partners share in the capital investment cost and profitability of the operations based on their respective ownership interests. For more information, please visit: www.ashs.com.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services including statements regarding the expected continued growth of the Company and the expansion of the Company’s Gamma Knife, proton therapy and advanced radiation therapy cancer treatment services businesses, which involve risks and uncertainties including, but not limited to, the risks of economic and market conditions, the risks of variability of financial results between quarters, the risks of the Gamma Knife, proton therapy and advanced radiation therapy cancer treatment services businesses, the risks of changes to CMS reimbursement rates or reimbursement methodology, the risks of the timing, financing, and operations of the Company’s Gamma Knife, proton therapy, and advanced radiation therapy cancer treatment services businesses, the risk of expanding within or into new markets, the risk that the integration or continued operation of acquired businesses could adversely affect financial results and the risk that current and future acquisitions may negatively affect the Company’s financial position. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2024.
Contacts:
American Shared Hospital Services
Ray Stachowiak, Executive Chairman and CEO
rstachowiak@ashs.com
Investor Relations
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com
FAQ
When is American Shared Hospital Services (AMS) Q2 2025 earnings call?
How can investors access American Shared Hospital Services (AMS) Q2 2025 earnings call?
What is the replay information for AMS Q2 2025 earnings call?
What services does American Shared Hospital Services (AMS) provide?
